BBIL/Bharat Biotech

Last updated: 13.02.2014

Address: Genome Valley ShameerpetHyderabad – 500 078 AP India

Tel: +91 40 2348 0567


Company description

(BBIL/Bharat Biotech), Hyderabad, India, is a multidimensional biotechnology company specialising in product-oriented research, development and manufacturing of vaccines and biotherapeutics. Bharat Biotech, established in the year 1996 by Dr. Krishna M. Ella & Mrs. Suchitra K. Ella as the Founder Directors, is engaged in developing next-generation vaccines and bio-therapeutics through innovative and collaborative research.

BBIL’s state-of-the-art manufacturing plant is the largest of its kind in Asia-Pacific. The first bio-pharma facility in the country to be audited and approved by Korean Food & Drugs Administration (KFDA), it sprawls over a picturesque campus at Genome Valley, Hyderabad. Built with an investment of over INR 1000 million, the facility’s Manufacturing, Control Procedures and Protocols, conform to the stringent standards laid down by internationally recognized institutions such as USFDA, UKMCA and WHO.

Bharat Biotech has set new benchmarks in Innovation and Quality that epitomizes the tremendous progress of Indian biotechnology in the global arena.

Products and services

Our business strategy is to research, develop, manufacture and market products that have a broad market scope. It also means of achieving Pioneering research. Healthy tomorrow. We build value by the skilled management of pre-clinical and clinical development, steering the process efficiently to the completion of clinical studies that demonstrate safety and efficacy.

-IMMUTIKA Vaccine Division
-RENOVA Bio-therapeutics Division
-PrefeRx Women Health Care Division


We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here